Hong Kong homebuyers deliver brisk weekend sales for developers, as small flats favoured
improving sentiment on the city's battered property market following a reduction in stamp duties and a buoyant stock market.
Advertisement
On Sunday, Sun Hung Kai Properties sold 96 of 172 units offered at its Yoho West Parkside development in Tin Shui Wai as of 5.20pm, 3.5 hours after the second round of sales there began. The developer sold all 119 flats in the first batch there on Wednesday, and expected the new batch to sell out on Sunday.
The one- to three-bedroom flats were priced between HK$2.98 million (US$373,000) and HK$10.57 million, or an average of HK$11,671 per square foot after discounts, 5 per cent higher than the first batch.
On Saturday, Henderson Land Development sold 40 out of 55 units it offered at Eight Southpark in Kowloon City, fetching some HK$188 million in total. The flats, measuring from 200 sq ft to 351 sq ft, were priced between HK$3.37 million and HK$8.1 million.
Buyers snapped up all flats priced below HK$4 million in the batch, the developer said. Overall, the project sold 221 out of 236 units, or 94 per cent of the available inventory, within eight days of launch, with a total haul of around HK$1.2 billion, it added.
Advertisement
'Both projects saw positive responses, considering they were the second round of sales,' said Sammy Po Siu-ming, CEO for the residential division at Midland Realty, one of the city's largest property agents.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
RTHK
5 minutes ago
- RTHK
HK stocks buoyed by signs of easing Sino-US tensions
HK stocks buoyed by signs of easing Sino-US tensions The Hang Seng Index ended the day up 129 points, or 0.51 percent, at 25,667. File photo: RTHK Mainland and Hong Kong stocks rose on Thursday as rare earth and tourism shares rallied as signs of easing China-US tensions lifted investor sentiment. In Hong Kong, the benchmark Hang Seng Index ended the day up 129 points, or 0.51 percent, at 25,667, the highest close since November 2021. Leading gains onshore, the rare earth sector surged 5.2 percent to a fresh three-year high. The tourism sector rose 3.4 percent, while China tourism group duty free index jumped by the 10 percent daily trading limit following a launch plan for the Hainan Free Trade Port. Chinese stocks have been steadily rising in recent weeks, buoyed by Beijing's efforts to curb excessive competition and overcapacity and signs of improving China-US trade relations. Up north, the benchmark Shanghai Composite Index rose 0.65 percent to 3,605 while the Shenzhen Component Index was up 1.21 percent at 11,193. The combined turnover of these two indexes stood at over 1.84 trillion yuan, down from 1.86 trillion yuan on Wednesday. Stocks related to Hainan Free Trade Port, rare-earth permanent magnet and lithium mineral led gains while stocks related to precious metal and banks suffered major losses. The ChiNext Index, tracking China's Nasdaq-style board of growth enterprises, gained 1.5 percent to close at 2,345. The Shanghai Composite Index has surged nearly 19 percent from its most recent low in April, nearing the 20 percent gain used to define a technical bull market. "Although there hasn't been any unexpected change in the top-down macroeconomic picture, there are still many structural opportunities within the stock market," analysts at Cinda Securities said in an note. Fresh signs of easing trade tensions between Beijing and Washington also helped lift sentiment. US President Donald Trump said on Wednesday that the United States was in the process of completing a trade deal with China. Around the region, MSCI's Asia ex-Japan stock index was up 0.3 percent, while Japan's Nikkei index gained 1.6 percent. (Reuters/Xinhua)
RTHK
5 minutes ago
- RTHK
'HK-made Chinese medicines to grow in popularity'
'HK-made Chinese medicines to grow in popularity' Wing Chu (left) says streamlined approval procedures offer more opportunities for Hong Kong-made proprietary Chinese medicines to be sold on the mainland. Photo: RTHK Hong Kong-made proprietary Chinese medicine products have great potential to enter mainland and overseas markets, the Hong Kong Trade Development Council said on Thursday. The mainland, which is the largest proprietary Chinese medicine market valued at 450 billion yuan, has streamlined the registration and approval procedures for products from Hong Kong. At a press conference, the council's principal economist of Greater China, Wing Chu, said Hong Kong's exports of proprietary Chinese medicines totalled HK$2.88 billion last year. More than 70 percent of the city's products were exported to the mainland, followed by 20 percent to Macau. Although the mainland mainly relies on its own drug production and only imports a small amount of Chinese medicines, over half of its imported proprietary Chinese medicines are from Hong Kong, Chu said. He added that the streamlined approval procedures offer more opportunities for Hong Kong businesses to expand into the Greater Bay Area and other mainland cities. 'Maybe Hong Kong-produced products are not the cheapest in the market, and there are a lot of alternative choices over there, but Hong Kong proprietary Chinese medicine products have a [good reputation] in mainland China, especially in the southern part of mainland China,' he said. Chu said there is also demand for Chinese medicines in overseas markets, particularly in Southeast Asia. 'But apart from this, there is also a lot of demand … even in the US or some European countries. They also have a demand for the traditional Chinese medicines. And this actually provides a very good market potential for us to explore,' he said. The council also said the opening of Hong Kong's first Chinese medicine hospital at the end of the year will help make proprietary Chinese medicines even more popular.
South China Morning Post
2 hours ago
- South China Morning Post
How mainland capital flight is reviving Hong Kong market's mojo
Since US President Donald Trump launched his assault on the global trading system in early April , one theme has dominated the financial market landscape. Contrary to the expectations of many investors, shifts in capital flows emerged as a more important determinant of sentiment than the economic impact of higher tariffs. Nowhere is this more apparent than in Asia, the region most at risk from the onslaught of protectionism because of its greater dependence on trade . The unexpected surge in Asian currencies in response to Trump's tariff blitz drew attention to many Asian economies' huge balance of payments surpluses, part of which were recycled into foreign assets, especially US Treasury bonds. Doubts over the willingness of Asian investors to continue to help fund the large US current account and fiscal deficits amid concerns about the safety of US assets fuelled speculation about 'de-dollarisation'. An alarming report by Eurizon SLJ Capital on May 6 predicted the US dollar – which suffered its worst start to the year since 1973 – faced an 'avalanche risk' as Asian investors began to unwind their huge stockpile of dollar holdings. However, while there is some evidence of a foreign buyers' strike, the US has yet to suffer capital outflows. In China, by contrast, layers of snow have been tumbling down for some time, particularly when it comes to foreign direct investment. Last year, net FDI plunged by US$168 billion, the biggest capital flight since 1990, according to data from the State Administration of Foreign Exchange (Safe). While inbound investment fell to just US$4.5 billion, outbound investment reached US$173 billion as Chinese companies continued to expand abroad The wave of outbound FDI attests to the economic and geopolitical forces pushing Chinese firms to shift part of their operations abroad in a trend reminiscent of Japanese companies' overseas investment spree in the 1980s. Yet while the previous surge in Chinese outbound investment in 2014-2016 was dominated by mergers and acquisitions, the current crop of foreign transactions is focused on greenfield projects – assets that are built as opposed to acquired – in emerging markets, especially Southeast Asia. According to a report by Rhodium Group last September, 'growing trade barriers abroad, pressure to diversify supply chains and the growing competitiveness of Chinese firms in advanced industries' have given rise to a 'new generation of China's overseas investment [with] very different objectives and destinations than in the previous decade'.
